What VDR does

Vitamin D does almost nothing on its own. It works by binding the vitamin D receptor inside the cell, and the receptor then acts as a transcription factor, switching on a large set of downstream genes involved in bone, immune function and calcium handling. The VDR gene builds that receptor.

This is why a blood level alone is an incomplete picture. Two people can carry the same serum 25-hydroxyvitamin D and get different amounts of biological work out of it, because the receptor reading that signal isn't identical between them.

What the variants change

Four VDR sites are well characterised in the literature and are the ones read in the MyGNLab panel: FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232) and a regulatory site at rs2107301.

FokI is the only one of the four that changes the protein itself. It shifts the start codon, producing a receptor that is three amino acids longer and measurably less active in transcription assays. The others sit in non-coding regions and are thought to act through messenger RNA stability and linkage with nearby functional sites, which is why their effects are more variable across populations.

Krasniqi and colleagues reviewed 77 studies of vitamin D pathway variants against vitamin D status, muscle mass and function, and found VDR variation associated with functional outcomes rather than with circulating level alone.3 Jia and colleagues pooled 26 studies on BsmI and osteoporosis risk.10 Ju and Zhu ran a meta-analysis with trial sequential analysis on rs2228570 and allergic rhinitis.11

What the human studies found

StudyPopulationFinding
Krasniqi et al., 20213Systematic review, 77 studiesVitamin D pathway variants, VDR included, associated with muscle mass and function, not only with serum level
Jia et al., 201310Meta-analysis, 26 studiesVDR BsmI genotype associated with osteoporosis risk
Clendenen et al., 201512734 breast cancer cases, 1,435 matched controlsNested case-control of vitamin D metabolism and signalling variants
Ju and Zhu, 202311Meta-analysis with trial sequential analysisrs2228570 associated with allergic rhinitis alongside vitamin D level
Wang et al., 20101Genome-wide association study, 33,996 individuals across 15 cohortsEstablished the common genetic determinants of vitamin D insufficiency
Lee et al., 202114Korean adults aged 40 and overSeason, dietary intake and vitamin D genetics interacted on serum 25(OH)D

What this means for a formula

Reduced receptor response doesn't mean vitamin D stops working. It means the level needed to produce a given amount of biological activity is higher than average. The practical consequence is a genotype-informed starting dose rather than a population default, confirmed against an actual blood test rather than assumed.

Vitamin K2 belongs in the same conversation. Vitamin D increases calcium absorption, and K2 activates the proteins that direct that calcium into bone rather than soft tissue. Pairing them is standard practice and it matters more, not less, at higher D doses.

Magnesium is the quiet third element. The enzymes that hydroxylate vitamin D into its active form are magnesium-dependent, so magnesium status affects how much of a given dose becomes usable.

Where the evidence is thinner. That VDR variants alter receptor function is well supported, most clearly for FokI, where the mechanism is a real change to the protein. What is less settled is the exact dose adjustment that should follow from a given genotype. The literature reports associations with outcomes rather than validated dosing multipliers, and effect sizes differ across ancestries and study designs. Treat a genotype-informed dose as a reasoned starting point that a blood test then confirms or corrects, not as a precise prescription.

What we do not test. Two other genes appear throughout the vitamin D literature: GC, which encodes the vitamin D binding protein, and CYP2R1, the main liver hydroxylase.1,2,4,6 Both influence circulating vitamin D. Neither is part of the 57-marker MyGNLab panel, and we don't report on them.

How MyGNLab uses this

The four VDR sites are read from your saliva sample as part of the 57-marker panel. Where the genotype predicts reduced receptor response, your formula starts vitamin D3 higher than the population default and pairs it with K2 and magnesium. Your report shows the genotype behind the number, so the recommendation and its basis sit on the same page.

References

  1. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–8.
  2. Duan L, Xue Z, Ji H, Zhang D, Wang Y. Effects of CYP2R1 gene variants on vitamin D levels and status: a systematic review and meta-analysis. Gene. 2018;678:361–9.
  3. Krasniqi E, Boshnjaku A, Wagner KH, Wessner B. Association between polymorphisms in vitamin D pathway-related genes, vitamin D status, muscle mass and function: a systematic review. Nutrients. 2021;13(9):3109.
  4. Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, Igo RP, et al. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyvitamin D concentrations. J Nutr. 2013;143(1):17–26.
  5. Petersen RA, Larsen LH, Damsgaard CT, Sørensen LB, Hjorth MF, Andersen R, et al. Common genetic variants are associated with lower serum 25-hydroxyvitamin D concentrations across the year among children at northern latitudes. Br J Nutr. 2017;117(6):829–38.
  6. Slater NA, Rager ML, Havrda DE, Harralson AF. Genetic variation in CYP2R1 and GC genes associated with vitamin D deficiency status. J Pharm Pract. 2017;30(1):31–6.
  7. Yu S, Feng Y, Qu C, Huo W, Zhang H, Ma J, et al. CYP27B1 as an instrument gene to investigate the causal relationship between vitamin D deficiency and obesity: a family-based study. Eur J Clin Nutr. 2020;74(5):806–10.
  8. Hyppönen E, Berry DJ, Wjst M, Power C. Serum 25-hydroxyvitamin D and IgE: a significant but non-linear relationship. Allergy. 2009;64(4):613–20.
  9. Kong AN, Fong CY, Ng CC, Mohamed AR, Khoo TB, Ng RL, et al. Association of common genetic variants with vitamin D status in Malaysian children with epilepsy. Seizure. 2020;79:103–11.
  10. Jia F, Sun RF, Li QH, Wang DX, Zhao F, Li JM, et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genet Test Mol Biomarkers. 2013;17(1):30–4.
  11. Ju F, Zhu R. Association of vitamin D levels and VDR variant (rs2228570) with allergic rhinitis: a meta-analysis and trial sequential analysis. Heliyon. 2023;9(6):e17283.
  12. Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Brinton LA, et al. Genetic polymorphisms in vitamin D metabolism and signaling genes and risk of breast cancer: a nested case-control study. PLoS One. 2015;10(10):e0140478.
  13. Kandemiş E, Tuncel G, Fahrioğlu U, Şah Ünal N, Mocan G, Ergören MÇ. Vitamin D deficiency rates and VDR polymorphisms in young Turkish Cypriot professionals. Cent Eur J Public Health. 2021;29(2):130–3.
  14. Lee J, Won Woo H, Kim J, Shin MH, Koh SB, Choi BY, et al. Independent and interactive associations of season, dietary vitamin D, and vitamin D-related genetic variants with serum 25(OH)D in Korean adults aged 40 years or older. Endocr J. 2021;68(6):701–11.

Prepared by MyGNLab from published human research. This review summarises studies conducted by third parties and is not a clinical trial run by MyGNLab. Food supplements are not a substitute for a varied, balanced diet. MyGNLab provides personalised nutrition, not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. High-dose vitamin D is not appropriate for everyone: if you are pregnant, nursing, have a kidney or parathyroid condition, or take medication, speak to your doctor before changing any supplement.

← All scientific reviews